Skip to content
OpenCapital
Get started

Context Therapeutics Inc. CNTX Q1 2026 earnings

Reported May 6, 2026 · Before market open

EPS-$0.09Beat by $0.03
EPS estimate-$0.12

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.10

Versus estimates

Diluted EPS

Q1 2026-$0.09Beat by $0.03
Q4 2025-$0.14Miss by $0.03Q3 2025-$0.10Miss by $0.01Q2 2025-$0.09Miss by $0.03Q1 2025-$0.05In lineQ4 2024-$0.04Beat by $0.01

Ask the moment Context Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Context Therapeutics Inc. report Q1 2026 earnings?
Context Therapeutics Inc. (CNTX) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Context Therapeutics Inc.'s Q1 2026 revenue and EPS?
Context Therapeutics Inc. reported eps of $-0.09 for Q1 2026.
Did Context Therapeutics Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.12 by $0.03.
How did Context Therapeutics Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 80.0% from $-0.05.
Where can I find Context Therapeutics Inc.'s Q1 2026 SEC filings?
You can read the 10-Q periodic report (0001628280-26-031267) directly on SEC EDGAR. The filing index links above go to sec.gov.